D C Talbot Selected Research

marimastat

7/2004

Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D C Talbot Research Topics

Disease

7	Neoplasms (Cancer) 06/2011 - 07/2001
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 03/2001
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2004 - 01/2000
3	Vomiting 01/2003 - 01/2000
2	Neutropenia 06/2003 - 05/2002
2	Melanoma (Melanoma, Malignant) 06/2000 - 01/2000
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Necrosis 07/2004
1	Thrombocytopenia (Thrombopenia) 06/2003
1	Sleepiness 01/2003
1	Disease Progression 05/2002
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2002
1	Breast Neoplasms (Breast Cancer) 05/2002
1	Myalgia 05/2002
1	Hand-Foot Syndrome 05/2002
1	Alopecia (Baldness) 05/2002
1	Bone Resorption 07/2001
1	Carcinoma (Carcinomatosis) 07/2000
1	Colorectal Neoplasms (Colorectal Cancer) 06/2000
1	Hypoxia (Hypoxemia) 06/2000

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 10/2003 - 01/2000
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 05/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004 - 07/2001
2	exatecan (DX 8951f)IBA 08/2003 - 06/2003
2	Cisplatin (Platino)FDA LinkGeneric 03/2001 - 06/2000
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2001 - 06/2000
2	Vinblastine (Vinblastine Sulfate)FDA Link 03/2001 - 01/2000
2	Fluorouracil (Carac)FDA LinkGeneric 07/2000 - 06/2000
2	Dacarbazine (DIC)FDA LinkGeneric 06/2000 - 01/2000
2	Tamoxifen FDA LinkGeneric 06/2000 - 01/2000
1	vistusertibIBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2011
1	Methotrexate (Mexate)FDA LinkGeneric 06/2011
1	Celecoxib (Celebrex)FDA Link 06/2011
1	Angiogenesis InhibitorsIBA 11/2004
1	Captopril (Capoten)FDA LinkGeneric 07/2004
1	marimastatIBA 07/2004
1	Dalteparin (Dalteparin Sodium)FDA Link 07/2004
1	tazarotene (Tazorac)FDA Link 09/2003
1	CamptothecinIBA 08/2003
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2003
1	Topoisomerase I InhibitorsIBA 06/2003
1	Carbon-11IBA 01/2003
1	acridine DACAIBA 01/2003
1	BilirubinIBA 01/2003
1	Capecitabine (Xeloda)FDA Link 05/2002
1	AnthracyclinesIBA 05/2002
1	Matrix Metalloproteinase InhibitorsIBA 07/2001
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2001
1	CGS 27023AIBA 07/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2001
1	Matrix Metalloproteinases (MMPs)IBA 07/2001
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2001
1	Urokinase Plasminogen Activator ReceptorsIBA 07/2001
1	Biological ProductsIBA 07/2001
1	CytokinesIBA 07/2001
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 07/2001
1	Tissue Inhibitor of Metalloproteinase-1IBA 07/2001
1	Tissue Inhibitor of Metalloproteinase-2IBA 07/2001
1	CathepsinsIBA 07/2001
1	RazoxaneIBA 12/2000
1	Topoisomerase II InhibitorsIBA 12/2000
1	Biomarkers (Surrogate Marker)IBA 12/2000
1	Interferon-alpha (Interferon Alfa)IBA 07/2000
1	Leucovorin (Folinic Acid)FDA Link 07/2000
1	Thymidine PhosphorylaseIBA 07/2000
1	Carmustine (FIVB)FDA Link 06/2000
1	5-(2-formyl-3-hydroxyphenoxy)pentanoic acidIBA 06/2000
1	AcidsIBA 06/2000
1	Oxygen (Dioxygen)IBA 06/2000
1	Toremifene (Fareston)FDA Link 01/2000
1	3-methyladenineIBA 01/2000
1	DNA (Deoxyribonucleic Acid)IBA 01/2000
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2000

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2018 - 01/2000
4	Therapeutics 07/2004 - 06/2000
1	Immunotherapy 11/2004
1	Intravenous Infusions 06/2003
1	DBPT regimen 06/2000